Host: Darryl S. Chutka, M.D.

Guest: Daniel M. Frendl, M.D., Ph.D.

If your practice includes middle age and older men, you’ve very likely diagnosed prostate cancer. It’s the most diagnosed non-skin cancer in men in the U.S. Its incidence rises with age, with a median age of around 66 years. When found early, prostate cancer is very treatable, and in most cases, curable. Prostate specific antigen, or PSA is very effective in detecting early prostate cancer, but its use has been controversial due to the risk of overdiagnosis and overtreatment. What are the current recommendations for prostate cancer screening with PSA? What’s the role of the digital rectal exam? How should we be using the PSA and what other tests are available for prostate cancer screening? The topic for this podcast is “Prostate Cancer Screening” and I’ll be asking these questions to my guest, Daniel M. Frendl, M.D., Ph.D., a urologist at the Arizona campus of the Mayo Clinic.

Tune in this Thursday for our next episode on "Prostate Cancer" releasing October 30, 2025.

Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts